Search Results - "Darras, Basil"

Refine Results
  1. 1

    Poly(lactic acid) (PLA) and polyhydroxyalkanoates (PHAs), green alternatives to petroleum-based plastics: a review by Naser, Ahmed Z, Deiab, I, Darras, Basil M

    Published in RSC advances (10-05-2021)
    “…In spite of the fact that petroleum-based plastics are convenient in terms of fulfilling the performance requirements of many applications, they contribute…”
    Get full text
    Journal Article
  2. 2

    Overturning the Paradigm of Spinal Muscular Atrophy as Just a Motor Neuron Disease by Yeo, Crystal Jing Jing, Darras, Basil T.

    Published in Pediatric neurology (01-08-2020)
    “…Spinal muscular atrophy is typically characterized as a motor neuron disease. Untreated patients with the most severe form, spinal muscular atrophy type 1, die…”
    Get full text
    Journal Article
  3. 3

    Spinal Muscular Atrophies by Darras, Basil T., MD

    Published in The Pediatric clinics of North America (01-06-2015)
    “…Spinal muscular atrophies (SMAs) are hereditary degenerative disorders of lower motor neurons associated with progressive muscle weakness and atrophy. Proximal…”
    Get full text
    Journal Article
  4. 4

    Challenges and opportunities in spinal muscular atrophy therapeutics by Yeo, Crystal J J, Tizzano, Eduardo F, Darras, Basil T

    Published in Lancet neurology (01-02-2024)
    “…Spinal muscular atrophy was the most common inherited cause of infant death until 2016, when three therapies became available: the antisense oligonucleotide…”
    Get full text
    Journal Article
  5. 5

    Risdiplam in Type 1 Spinal Muscular Atrophy by Baranello, Giovanni, Darras, Basil T, Day, John W, Deconinck, Nicolas, Klein, Andrea, Masson, Riccardo, Mercuri, Eugenio, Rose, Kristy, El-Khairi, Muna, Gerber, Marianne, Gorni, Ksenija, Khwaja, Omar, Kletzl, Heidemarie, Scalco, Renata S, Seabrook, Timothy, Fontoura, Paulo, Servais, Laurent

    Published in The New England journal of medicine (11-03-2021)
    “…The small molecule risdiplam increased the expression of SMN protein in blood in 21 infants with type 1 spinal muscular atrophy. Post hoc clinical features of…”
    Get full text
    Journal Article Web Resource
  6. 6
  7. 7

    Results from a phase 1 study of nusinersen (ISIS-SMNRx) in children with spinal muscular atrophy by Chiriboga, Claudia A, Swoboda, Kathryn J, Darras, Basil T, Iannaccone, Susan T, Montes, Jacqueline, De Vivo, Darryl C, Norris, Daniel A, Bennett, C Frank, Bishop, Kathie M

    Published in Neurology (08-03-2016)
    “…OBJECTIVE:To examine safety, tolerability, pharmacokinetics, and preliminary clinical efficacy of intrathecal nusinersen (previously ISIS-SMNRx), an antisense…”
    Get full text
    Journal Article
  8. 8

    Systemic nature of spinal muscular atrophy revealed by studying insurance claims by Lipnick, Scott L, Agniel, Denis M, Aggarwal, Rahul, Makhortova, Nina R, Finlayson, Samuel G, Brocato, Alexandra, Palmer, Nathan, Darras, Basil T, Kohane, Isaac, Rubin, Lee L

    Published in PloS one (14-03-2019)
    “…We investigated the presence of non-neuromuscular phenotypes in patients affected by Spinal Muscular Atrophy (SMA), a disorder caused by a mutation in the…”
    Get full text
    Journal Article
  9. 9

    Spinal muscular atrophy by Mercuri, Eugenio, Sumner, Charlotte J., Muntoni, Francesco, Darras, Basil T., Finkel, Richard S.

    Published in Nature reviews. Disease primers (04-08-2022)
    “…Spinal muscular atrophy (SMA) is a neurodegenerative disorder caused by mutations in SMN1 (encoding survival motor neuron protein (SMN)). Reduced expression of…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    An Integrated Safety Analysis of Infants and Children with Symptomatic Spinal Muscular Atrophy (SMA) Treated with Nusinersen in Seven Clinical Trials by Darras, Basil T., Farrar, Michelle A., Mercuri, Eugenio, Finkel, Richard S., Foster, Richard, Hughes, Steven G., Bhan, Ishir, Farwell, Wildon, Gheuens, Sarah

    Published in CNS drugs (01-09-2019)
    “…Background Treatment with nusinersen has demonstrated significant and clinically meaningful benefits in clinical trials in infants and children with spinal…”
    Get full text
    Journal Article
  17. 17

    Dystrophinopathies by Brandsema, John F, Darras, Basil T

    Published in Seminars in neurology (01-08-2015)
    “…The dystrophinopathies fall along a spectrum of muscular dystrophy phenotypes, with variable involvement of skeletal and cardiac muscle. The diagnosis of…”
    Get more information
    Journal Article
  18. 18

    Cyber-Physical Systems as an Enabler of Circular Economy to Achieve Sustainable Development Goals: A Comprehensive Review by Ahmed, Aser Alaa, Nazzal, Mohammad A., Darras, Basil M.

    “…Industrialization has brought wealth, prosperity, and abundance to many nations. However, it has had many drawbacks on people’s health and the environment…”
    Get full text
    Journal Article
  19. 19
  20. 20